Hospira Inc patents expiration
1. Daptomycin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10357535 | HOSPIRA INC | Daptomycin formulations and uses thereof |
Sep, 2033
(9 years from now) | |
| US9655946 | HOSPIRA INC | Daptomycin formulations and uses thereof |
Sep, 2033
(9 years from now) | |
Drugs and Companies using DAPTOMYCIN ingredient
Market Authorisation Date: 21 June, 2021
Treatment: Treatment of complicated skin and skin structure infections and s. aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis by reconstituting and administerin...
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
DAPTOMYCIN family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic